Identification of microRNA-target interaction in APRIL-knockdown colorectal cancer cells

Cancer Gene Therapy

Volumn 18, Issue 7, 2011, Pages 500-509

  Wang, F ^a   Ding, W ^a   Wang, J ^a   Jing, R ^a   Wang, X ^a   Cong, H ^a   Wang, Y ^a   Ju, S ^a   Wang, H ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

APRIL; colorectal cancer; microarray; microRNA; siRNA

Indexed keywords

APRIL PROTEIN; MICRORNA;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; COLORECTAL CANCER; GENE SILENCING; GENETIC ANALYSIS; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN RNA BINDING;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL SURVIVAL; COLORECTAL NEOPLASMS; FLOW CYTOMETRY; GENETIC VECTORS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13;

MAMMALIA;

EID: 79959380837     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/cgt.2011.19     Document Type: Article

References (36)

1. Olena AF, Patton JG. Genomic organization of micro- RNAs. J Cell Physiol 2010; 222: 540-545.
2. Friedman JM, Jones PA. MicroRNAs: critical mediators of differentiation, development and disease. Swiss Med Wkly 2009; 139: 466-472.
3. Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science 2007; 318: 1931-1934.
4. Chua JH, Armugam A, Jeyaseelan K. MicroRNAs: biogenesis, function and applications. Curr Opin Mol Ther 2009; 11: 189-199.
5. Iwasaki S, Tomari Y. Argonaute-mediated translational repression (and activation). Fly (Austin) 2009; 3: 204-206.
6. Saunders MA, Lim LP. (micro)Genomic medicine: micro- RNAs as therapeutics and biomarkers. RNA Biol 2009; 6: 324-328.
7. Yang BF, Lu YJ, Wang ZG. MicroRNAs and apoptosis: implications in the molecular therapy of human disease. Clin Exp Pharmacol Physiol 2009; 36: 951-960.
8. Tang JT, Fang JY. MicroRNA regulatory network in human colorectal cancer. Mini Rev Med Chem 2009; 9: 921-926.
9. Motoyama K, Inoue H, Takatsuno Y, Tanaka F, Mimori K, Uetake H et al. Over- and under-expressed microRNAs in human colorectal cancer. Int J Oncol 2009; 34: 1069-1075.
10. Valeri N, Croce CM, Fabbri M. Pathogenetic and clinical relevance of microRNAs in colorectal cancer. Cancer Genomics Proteomics 2009; 6: 195-204.
11. Faber C, Kirchner T, Hlubek F. The impact of microRNAs on colorectal cancer. Virchows Arch 2009; 454: 359-367.
12. Hahne M, Kataoka T, Schroter M, Hofmann K, Irmler M, Bodmer JL et al. APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J Exp Med 1998; 188: 1185-1190. (Pubitemid 28443341)
13. Gu D, Ge J, Du W, Xue F, Chen Z, Zhao H et al. Raised expression of APRIL in Chinese patients with immune thrombocytopenia and its clinical implications. Autoimmunity 2009; 42: 692-698.
14. Kimberley FC, van Bostelen L, Cameron K, Hardenberg G, Marquart JA, Hahne M et al. The proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization and cross-linking. FASEB J 2009; 23: 1584-1595.
15. Sun B, Wang H, Wang X, Huang H, Ding W, Jing R et al. A proliferation- inducing ligand: a new biomarker for nonsmall cell lung cancer. Exp Lung Res 2009; 35: 486-500.
16. Mhawech-Fauceglia P, Kaya G, Sauter G, McKee T, Donze O, Schwaller J et al. The source of APRIL up-regulation in human solid tumor lesions. J Leukoc Biol 2006; 80: 697-704. (Pubitemid 44835884)
17. Planelles L, Medema JP, Hahne M, Hardenberg G. The expanding role of APRIL in cancer and immunity. Curr Mol Med 2008; 8: 829-844.
18. Wang F, Chen L, Mao ZB, Shao JG, Tan C, Huang WD. Lentivirus- mediated short hairpin RNA targeting the APRIL gene suppresses the growth of pancreatic cancer cells in vitro and in vivo. Oncol Rep 2008; 20: 135-139.
19. Moreaux J, Veyrune JL, De Vos J, Klein B. APRIL is overexpressed in cancer: link with tumor progression. BMC Cancer 2009; 9: 83.
20. Ding W, Wang J, Sun B, Ju S, Yuan H, Wang X et al. APRIL knockdown suppresses migration and invasion of human colon carcinoma cells. Clin Biochem 2009; 42: 1694-1698.
21. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 2003; 31: e15.
22. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003; 4: 249-264.
23. Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer. CA Cancer J Clin 2009; 59: 366-378.
24. Markowitz SD, Bertagnolli MM. Molecular origins of cancer: molecular basis of colorectal cancer. N Engl J Med 2009; 361: 2449-2460.
25. Ortega J, Vigil CE, Chodkiewicz C. Current progress in targeted therapy for colorectal cancer. Cancer Control 2010; 17: 7-15.
26. Dykxhoorn DM. RNA interference as an anticancer therapy: a patent perspective. Expert Opin Ther Pat 2009; 19: 475-491.
27. Wang SL, Yao HH, Qin ZH. Strategies for short hairpin RNA delivery in cancer gene therapy. Expert Opin Biol Ther 2009; 9: 1357-1368.
28. Gregersen LH, Jacobsen AB, Frankel LB, Wen J, Krogh A, Lund AH. MicroRNA-145 targets YES and STAT1 in colon cancer cells. PLoS One 2010; 5: e8836.
29. Schepeler T, Reinert JT, Ostenfeld MS, Christensen LL, Silahtarogl AN, Dyrskjot L et al. Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res 2008; 68: 6416-6424.
30. Wang CJ, Zhou ZG, Wang L, Yang L, Zhou B, Gu J et al. Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer. Dis Markers 2009; 26: 27-34.
31. Slaby O, Svoboda M, Fabian P, Smerdova T, Knoflickova D, Bednarikova M et al. Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 2007; 72: 397-402. (Pubitemid 351238155)
32. Satyanarayana A, Kaldis P. Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms. Oncogene 2009; 28: 2925-2939.
33. Kapuy O, He E, Lopez-Aviles S, Uhlmann F, Tyson JJ, Novak B. System-level feedbacks control cell cycle progression. FEBS Lett 2009; 583: 3992-3998.
34. Malumbres M, Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 2009; 9: 153-166.
35. Li J, Min R, Bonner A, Zhang Z. A probabilistic framework to improve microrna target prediction by incorporating proteomics data. J Bioinform Comput Biol 2009; 7: 955-972.
36. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008; 455: 58-63.